Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter studyTatsuya Ide, Takuji Torimura, Nobito Higuchi et al.|Hepatology International|2019Cited by 56
Predictors of hepatocellular carcinoma recurrence associated with the use of direct‐acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort studyMasahito Nakano, Takuji Torimura, Hironori Koga et al.|Cancer Medicine|2019Cited by 38
Metabolic management after sustained virologic response in elderly patients with hepatitis C virus: A multicenter studyTomoya Sano, Keisuke Amano, Tatsuya Ide et al.|Hepatology Research|2023Cited by 23